Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul 1;63(1):133-137.
doi: 10.1093/cid/ciw213. Epub 2016 Apr 7.

Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV

Affiliations

Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV

Russell B Van Dyke et al. Clin Infect Dis. .

Abstract

Among 234 US youths with perinatal human immunodeficiency virus, 75% had antiretroviral resistance, substantially higher than that of the reference laboratory overall (36%-44%). Resistance to newer antiretrovirals and to all antiretrovirals in a class was uncommon. The only factor independently associated with future resistance was a higher peak viral load.

Keywords: adolescents; antiviral resistance; children; human immunodeficiency virus; perinatal infection.

PubMed Disclaimer

References

    1. de Mulder M, Yebra G, Navas A et al. . Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis. Pediatr Infect Dis J 2012; 31:e213–21. - PubMed
    1. Paredes R, Lalama CM, Ribaudo HJ et al. . Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure. J Infect Dis 2010; 201:662–71. - PMC - PubMed
    1. Hogg RS, Bangsberg DR, Lima VD et al. . Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART. PLoS Med 2006; 3:e356. - PMC - PubMed
    1. Gardner EM, Hullsiek KH, Telzak EE et al. . Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trial. AIDS 2010; 24:395–403. - PMC - PubMed
    1. Bangsberg DR, Porco TC, Kagay C et al. . Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates. J Infect Dis 2004; 190:162–5. - PubMed

Publication types

Substances